Skip to Main Content

Paper Details

Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.
Nat Med
357
2018
CAR, CAR19, CD19, acute lymphoblastic leukemia, chimeric antigen receptor, resistant, resistant tumor cells, tumor
Author NameAffiliation
Rebecca J LearyNovartis Institutes for BioMedical Research
Markus RiesterNovartis Institutes for BioMedical Research
Markus RiesterNovartis Institutes for BioMedical Research
Stephan A GruppChildren's Hospital of Philadelphia
Eneida R NemecekOregon Health & Science University
Hans BitterNovartis Institutes for BioMedical Research
Michael MorrisseyNovartis Institutes for BioMedical Research
Wendy WincklerNovartis Institutes for BioMedical Research
  • 1 - 8

Datasets

Release 1.2